Literature DB >> 21322396

Contrast-enhanced ultrasound of the normal canine prostate gland.

Enrico Bigliardi1, Layla Ferrari.   

Abstract

Canine prostate gland abnormalities affect a large number of adult male dogs. In veterinary medicine, the commonly used methods to diagnose canine prostate gland disease are digital rectal examination and abdominal ultrasound. We evaluated the ability of ultrasound contrast agent to provide additional information about the vascularity of the canine prostate gland; such information could be useful in detecting early prostate gland disease and in staging disease known to be present. We characterized the ultrasonographic appearance of prostate gland vascularity in 10 healthy dogs before and after the injection of an ultrasound contrast agent (Levovist). Before injecting Levovist, the prostate gland blood flow was classified as poor in all dogs, whereas after contrast agent injection blood flow was classified as moderate or good, in 3 and 7 dogs respectively. Knowledge of the status of prostate gland vascularity could be useful for the characterization, diagnosis and therapeutic monitoring of canine prostate gland lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21322396

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  2 in total

1.  Use of platelet-rich plasma for the treatment of prostatic cysts in dogs.

Authors:  Enrico Bigliardi; Anna Maria Cantoni; Valeria De Cesaris; Laura Denti; Virna Conti; Mara Bertocchi; Francesco Di Ianni; Enrico Parmigiani; Stefano Grolli
Journal:  Can J Vet Res       Date:  2018-10       Impact factor: 1.310

2.  Monitoring the reproductive activity in captive bred female ball pythons (P. regius) by ultrasound evaluation and noninvasive analysis of faecal reproductive hormone (progesterone and 17β-estradiol) metabolites trends.

Authors:  Mara Bertocchi; Igor Pelizzone; Enrico Parmigiani; Patrizia Ponzio; Elisabetta Macchi; Federico Righi; Nicola Di Girolamo; Enrico Bigliardi; Laura Denti; Carla Bresciani; Francesco Di Ianni
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.